Literature DB >> 30126542

Differential relationships of PTSD and childhood trauma with the course of substance use disorders.

Michaela Mergler1, Martin Driessen2, Ursula Havemann-Reinecke3, Dirk Wedekind4, Christel Lüdecke5, Martin Ohlmeier6, Claudia Chodzinski7, Sibylle Teunißen8, Steffen Weirich9, Ulrich Kemper10, Walter Renner11, Ingo Schäfer12.   

Abstract

A large body of research documents the link between Posttraumatic Stress Disorder (PTSD) and the course of Substance Use Disorders (SUD). Similar relationships have been reported between Childhood Trauma (CT) and the course of illness in patients with SUD even in the absence of PTSD, but few studies have examined differential effects of PTSD and CT (independent of PTSD) in this population. We used the International Diagnostic Checklist (IDCL) and the Posttraumatic Diagnostic Scale (PDS) to diagnose PTSD in a sample of patients with SUD (N = 459). The Childhood Trauma Questionnaire (CTQ) and the European Addiction Severity Index (EuropASI) were administered to assess childhood trauma and addiction related problems including comorbid psychopathological symptoms. The sample was divided into three groups: patients with experiences of CT and PTSD (CT-PTSD), experiences of CT without PTSD (CT-only), and neither experiences of CT nor PTSD (No trauma) to examine their differential associations with the course and severity of SUD. Patients of both the CT-PTSD (n = 95) and the CT-only group (n = 134) reported significantly higher levels of anxiety and depression as well as more suicidal thoughts and suicide attempts during their lifetime than the No trauma group (n = 209). Regarding most variables a graded association became apparent, with the highest level of symptoms in the CT-PTSD group, an intermediate level in the CT-only group and the lowest level in the No trauma group. The CT-PTSD group also differed in almost all substance use variables significantly from the No trauma group, including a younger age at first use of alcohol and cannabis, more cannabis use in the last month, and more lifetime drug overdoses. Our results confirm the relationships of both CT and PTSD with psychiatric symptoms in patients with SUD. Thus, it seems important to include both domains into the routine assessment of SUD patients. Specific treatments for comorbid PTSD but also for other consequences of childhood trauma should be integrated into SUD treatment programs.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Childhood trauma; Posttraumatic stress disorder; Substance use disorder

Mesh:

Year:  2018        PMID: 30126542     DOI: 10.1016/j.jsat.2018.07.010

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  5 in total

1.  Influences of victimization and comorbid conditions on substance use disorder outcomes in justice-involved youth: A discrete time survival mixture analysis.

Authors:  Jordan P Davis; Tim Janssen; Emily R Dworkin; Tara M Dumas; Jeremy Goldbach; John Monterosso
Journal:  Dev Psychopathol       Date:  2020-08

2.  The impact of trauma characteristics on post-traumatic stress disorder and substance use disorder outcomes across integrated and substance use treatments.

Authors:  Skye Fitzpatrick; Tanya Saraiya; Teresa Lopez-Castro; Lesia M Ruglass; Denise Hien
Journal:  J Subst Abuse Treat       Date:  2020-01-22

Review 3.  Gender Dynamics in Substance Use and Treatment: A Women's Focused Approach.

Authors:  Miriam T H Harris; Jordana Laks; Natalie Stahl; Sarah M Bagley; Kelley Saia; Wendee M Wechsberg
Journal:  Med Clin North Am       Date:  2022-01       Impact factor: 5.456

4.  Commentary on Nower et al: Patterns in pathways: underlying comorbidities and the importance of assessment.

Authors:  Anna E Goudriaan; Marleen M de Waal
Journal:  Addiction       Date:  2022-03-21       Impact factor: 7.256

5.  Cannabis Use in People With Obsessive-Compulsive Symptomatology: Results From a Mexican Epidemiological Sample.

Authors:  Humberto Nicolini; José Jaime Martínez-Magaña; Alma Delia Genis-Mendoza; Jorge Ameth Villatoro Velázquez; Beatriz Camarena; Clara Fleiz Bautista; Marycarmen Bustos-Gamiño; Alejandro Aguilar García; Nuria Lanzagorta; María Elena Medina-Mora
Journal:  Front Psychiatry       Date:  2021-05-10       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.